These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 25545307)

  • 1. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.
    Drago F; Ciccarese G; Javor S; Parodi A
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):544-5. PubMed ID: 25545307
    [No Abstract]   [Full Text] [Related]  

  • 2. Pityriasis rosea and pityriasis rosea-like eruptions.
    Drago F; Broccolo F; Agnoletti A; Drago F; Rebora A; Parodi A
    J Am Acad Dermatol; 2014 Jan; 70(1):196. PubMed ID: 24355268
    [No Abstract]   [Full Text] [Related]  

  • 3. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
    Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
    J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to: Pityriasis rosea and pityriasis rosea-like eruptions.
    Papadavid E; Panayiotides I; Dalamaga M; Giatrakou S; Stavrianeas N; Rigopoulos D; Makris M
    J Am Acad Dermatol; 2014 Jan; 70(1):196-7. PubMed ID: 24355267
    [No Abstract]   [Full Text] [Related]  

  • 5. Pityriasis rosea-like eruption due to bismuth.
    Hanjani NM; Rencic A; Whitmore SE
    Cutis; 2006 Mar; 77(3):166-8. PubMed ID: 16610736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.
    Ciccarese G; Parodi A; Drago F
    Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical pityriasis rosea: clinical evaluation of 27 patients.
    Kilinc F; Akbas A; Sener S; Aktaş A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):157-162. PubMed ID: 27558764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pityriasis rosea-like adverse reaction induced by pristinamycine].
    Mokni S; Belhadjali H; Alkhalifa J; Njim L; Youssef M; Chaabène A; Zili J
    Therapie; 2013; 68(5):326-8. PubMed ID: 24225045
    [No Abstract]   [Full Text] [Related]  

  • 9. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.
    Atzori L; Pinna AL; Ferreli C; Aste N
    Dermatol Online J; 2006 Jan; 12(1):1. PubMed ID: 16638369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rosea-like drug eruption due to bupropion: a case report.
    Polat M; Uzun Ö; Örs I; Boran Ç
    Hum Exp Toxicol; 2014 Dec; 33(12):1294-6. PubMed ID: 24700110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pityriasis rosea-like eruption associated with lamotrigine.
    Papadavid E; Panayiotides I; Makris M; Giatrakou S; Dalamaga M; Stavrianeas N; Rigopoulos D
    J Am Acad Dermatol; 2013 Jun; 68(6):e180-1. PubMed ID: 23680210
    [No Abstract]   [Full Text] [Related]  

  • 12. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent pityriasis rosea: A case report.
    Li A; Li P; Li Y; Li W
    Hum Vaccin Immunother; 2018 Apr; 14(4):1024-1026. PubMed ID: 29182459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis rosea-like eruption in a patient receiving omeprazole.
    Buckley C
    Br J Dermatol; 1996 Oct; 135(4):660-1. PubMed ID: 8915176
    [No Abstract]   [Full Text] [Related]  

  • 15. Pityriasis rosea-like eruption induced by isotretinoin.
    Gürel G; Şahin S; Çölgeçen E
    Cutan Ocul Toxicol; 2018 Mar; 37(1):100-102. PubMed ID: 28359163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis rosea and activation of latent herpesvirus infections.
    Schwartz RA; Lambert WC
    J Am Acad Dermatol; 2014 Jan; 70(1):197. PubMed ID: 24355270
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathologic features of pityriasis rosea-like drug eruption secondary to imatinib: A case report and review of the literature.
    Durgin JS; Whittington CP; Harrell J; Mervak JE; Smith EH
    J Cutan Pathol; 2024 Nov; 51(11):860-865. PubMed ID: 39021288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral pityriasis rosea in a child: A rare clinical presentation.
    Oğrum A
    Turk J Pediatr; 2017; 59(2):214-216. PubMed ID: 29276879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis rosea-like drug reaction to asenapine.
    Makdisi J; Amin B; Friedman A
    J Drugs Dermatol; 2013 Sep; 12(9):1050-1. PubMed ID: 24002155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.
    Bangash HK; Finch T; Petronic-Rosic V; Sethi A; Abramsohn E; Lindau ST
    J Low Genit Tract Dis; 2013 Apr; 17(2):226-9. PubMed ID: 23343697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.